# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Jul 16, 2024

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2024-07-16
- Accepted by EDGAR: Jul 16, 2024, 21:23 ET
- Period: 2024-07-10
- Accession: 0001104659-24-080251
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465924080251/tm2419633d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465924080251/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465924080251/tm2419633d1_8k.htm

Filed Jul 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-080251. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.